Paul M. Lieberman - Publications

Affiliations: 
Cell and Molecular Biology University of Pennsylvania, Philadelphia, PA, United States 
Area:
Virology Biology, Molecular Biology, Immunology

192 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Preston-Alp S, Caruso LB, Su C, Keith K, Soldan SS, Maestri D, Madzo J, Kossenkov A, Napoletani G, Gewurz B, Lieberman PM, Tempera I. Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer. Mbio. e0039623. PMID 37606370 DOI: 10.1128/mbio.00396-23  0.38
2023 Dheekollu J, Wiedmer A, Soldan SS, Castro-Muñoz LJ, Chen C, Tang HY, Speicher DW, Lieberman PM. Regulation of EBNA1 protein stability and DNA replication activity by PLOD1 lysine hydroxylase. Plos Pathogens. 19: e1010478. PMID 37262099 DOI: 10.1371/journal.ppat.1010478  0.455
2023 Li F, Wang Y, Hwang I, Jang JY, Xu L, Deng Z, Yu EY, Cai Y, Wu C, Han Z, Huang YH, Huang X, Zhang L, Yao J, Lue NF, ... Lieberman PM, et al. Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenance. Nature Communications. 14: 1756. PMID 36991019 DOI: 10.1038/s41467-023-37480-2  0.3
2023 Li F, Wang Y, Hwang I, Jang JY, Xu L, Deng Z, Yu EY, Cai Y, Wu C, Han Z, Huang YH, Huang X, Zhang L, Yao J, Lue NF, ... Lieberman PM, et al. Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenance. Biorxiv : the Preprint Server For Biology. PMID 36798426 DOI: 10.1101/2023.02.10.528023  0.301
2023 Dunn LEM, Lu F, Su C, Lieberman PM, Baines JD. Reactivation of Epstein-Barr Virus from Latency Involves Increased RNA Polymerase Activity at CTCF Binding Sites on the Viral Genome. Journal of Virology. 97: e0189422. PMID 36744959 DOI: 10.1128/jvi.01894-22  0.459
2022 Kim KD, Lieberman PM. 4C Analysis of EBV-Host DNA Interactome. Methods in Molecular Biology (Clifton, N.J.). 2610: 99-107. PMID 36534285 DOI: 10.1007/978-1-0716-2895-9_9  0.366
2022 Mei Y, Messick TE, Dheekollu J, Kim HJ, Molugu S, Muñoz LJC, Moiskeenkova-Bell V, Murakami K, Lieberman PM. Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus . Journal of Virology. e0094922. PMID 36037477 DOI: 10.1128/jvi.00949-22  0.512
2022 Gulve N, Su C, Deng Z, Soldan SS, Vladimirova O, Wickramasinghe J, Zheng H, Kossenkov AV, Lieberman PM. DAXX-ATRX regulation of p53 chromatin binding and DNA damage response. Nature Communications. 13: 5033. PMID 36028493 DOI: 10.1038/s41467-022-32680-8  0.393
2022 Morgan SM, Tanizawa H, Caruso LB, Hulse M, Kossenkov A, Madzo J, Keith K, Tan Y, Boyle S, Lieberman PM, Tempera I. The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity. Nature Communications. 13: 187. PMID 35039491 DOI: 10.1038/s41467-021-27894-1  0.428
2021 Su C, Lu F, Soldan SS, Lamontagne RJ, Tang HY, Napoletani G, Farrell PJ, Tempera I, Kossenkov AV, Lieberman PM. EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes. Plos Pathogens. 17: e1009834. PMID 34352044 DOI: 10.1371/journal.ppat.1009834  0.33
2021 Singh RK, Pei Y, Bose D, Lamplugh ZL, Sun K, Yuan Y, Lieberman P, You J, Robertson ES. KSHV-encoded vCyclin can modulate HIF1α levels to promote DNA replication in hypoxia. Elife. 10. PMID 34279223 DOI: 10.7554/eLife.57436  0.4
2021 Lu F, Martin KA, Soldan SS, Kossenkov AV, Wickramasinghe P, Vladimirova O, De Leo A, Lin C, Nefedova Y, Lieberman PM. Defective Epstein-Barr Virus Genomes and Atypical Viral Gene Expression in B-Cell Lines Derived from Multiple Myeloma Patients. Journal of Virology. PMID 33883224 DOI: 10.1128/JVI.00088-21  0.338
2021 Lang F, Li X, Vladimirova O, Hu B, Chen G, Xiao Y, Singh V, Lu D, Li L, Han H, Wickramasinghe JMASP, Smith ST, Zheng C, Li Q, Lieberman PM, et al. Author Correction: CTCF interacts with the lytic HSV-1 genome to promote viral transcription. Scientific Reports. 11: 5039. PMID 33633299 DOI: 10.1038/s41598-021-84469-2  0.317
2021 Mei Y, Deng Z, Vladimirova O, Gulve N, Johnson FB, Drosopoulos WC, Schildkraut CL, Lieberman PM. TERRA G-quadruplex RNA interaction with TRF2 GAR domain is required for telomere integrity. Scientific Reports. 11: 3509. PMID 33568696 DOI: 10.1038/s41598-021-82406-x  0.355
2021 Lamontagne RJ, Soldan SS, Su C, Wiedmer A, Won KJ, Lu F, Goldman AR, Wickramasinghe J, Tang HY, Speicher DW, Showe L, Kossenkov AV, Lieberman PM. A multi-omics approach to Epstein-Barr virus immortalization of B-cells reveals EBNA1 chromatin pioneering activities targeting nucleotide metabolism. Plos Pathogens. 17: e1009208. PMID 33497421 DOI: 10.1371/journal.ppat.1009208  0.342
2021 Dheekollu J, Wiedmer A, Ayyanathan K, Deakyne JS, Messick TE, Lieberman PM. Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance. Cell. PMID 33482082 DOI: 10.1016/j.cell.2020.12.022  0.513
2021 Vladimirova O, De Leo A, Deng Z, Wiedmer A, Hayden J, Lieberman PM. Phase separation and DAXX redistribution contribute to LANA nuclear body and KSHV genome dynamics during latency and reactivation. Plos Pathogens. 17: e1009231. PMID 33471863 DOI: 10.1371/journal.ppat.1009231  0.358
2020 Soldan SS, Lieberman PM. Epstein-Barr virus infection in the development of neurological disorders Drug Discovery Today: Disease Models. 32: 35-52. PMID 33897799 DOI: 10.1016/J.Ddmod.2020.01.001  0.348
2020 Drosopoulos WC, Deng Z, Twayana S, Kosiyatrakul ST, Vladimirova O, Lieberman PM, Schildkraut CL. TRF2 Mediates Replication Initiation within Human Telomeres to Prevent Telomere Dysfunction. Cell Reports. 33: 108379. PMID 33176153 DOI: 10.1016/j.celrep.2020.108379  0.422
2020 Wang Q, Zhu N, Hu J, Wang Y, Xu J, Gu Q, Lieberman PM, Yuan Y. The mTOR Inhibitor Manassantin B Reveals A Crucial Role of mTORC2 Signaling in Epstein-Barr Virus Reactivation. The Journal of Biological Chemistry. PMID 32312752 DOI: 10.1074/Jbc.Ra120.012645  0.401
2020 Messick TE, Tolvinski L, Zartler ER, Moberg A, Frostell Å, Smith GR, Reitz AB, Lieberman PM. Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA. Molecules (Basel, Switzerland). 25. PMID 32290261 DOI: 10.3390/Molecules25071760  0.517
2020 Kim KD, Tanizawa H, De Leo A, Vladimirova O, Kossenkov A, Lu F, Showe LC, Noma KI, Lieberman PM. Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus. Nature Communications. 11: 877. PMID 32054837 DOI: 10.1038/S41467-019-14152-8  0.523
2020 Lidenge SJ, Kossenkov AV, Tso FY, Wickramasinghe J, Privatt SR, Ngalamika O, Ngowi JR, Mwaiselage J, Lieberman PM, West JT, Wood C. RNA-seq sample quality and alignment statistics. Plos Pathogens. DOI: 10.1371/Journal.Ppat.1008681.S007  0.325
2020 Lamontagne J, Wiedmer A, Lieberman PM. Abstract IA10: Epigenetic remodeling of host metabolic pathways by Epstein-Barr virus (EBV) immortalization Cancer Research. 80. DOI: 10.1158/1538-7445.Mvc2020-Ia10  0.509
2019 De Leo A, Calderon A, Lieberman PM. Control of Viral Latency by Episome Maintenance Proteins. Trends in Microbiology. PMID 31624007 DOI: 10.1016/j.tim.2019.09.002  0.397
2019 Zhao B, Lin J, Rong L, Wu S, Deng Z, Fatkhutdinov N, Zundell J, Fukumoto T, Liu Q, Kossenkov A, Jean S, Cadungog MG, Borowsky ME, Drapkin R, Lieberman PM, et al. ARID1A promotes genomic stability through protecting telomere cohesion. Nature Communications. 10: 4067. PMID 31492885 DOI: 10.1038/S41467-019-12037-4  0.358
2019 Singh RK, Lamplugh ZL, Lang F, Yuan Y, Lieberman P, You J, Robertson ES. KSHV-encoded LANA protects the cellular replication machinery from hypoxia induced degradation. Plos Pathogens. 15: e1008025. PMID 31479497 DOI: 10.1371/Journal.Ppat.1008025  0.541
2019 Li F, Deng Z, Zhang L, Wu C, Jin Y, Hwang I, Vladimirova O, Xu L, Yang L, Lu B, Dheekollu J, Li JY, Feng H, Hu J, Vakoc CR, ... ... Lieberman PM, et al. ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization. The Embo Journal. e96659. PMID 31454099 DOI: 10.15252/Embj.201796659  0.491
2019 Dheekollu J, Malecka K, Wiedmer A, Delecluse HJ, Chiang AKS, Altieri DC, Messick TE, Lieberman PM. Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency. Oncotarget. 10: 4505-4506. PMID 31327987 DOI: 10.18632/Oncotarget.27073  0.302
2019 Tikhmyanova N, Paparoidamis N, Romero-Masters J, Feng X, Mohammed FS, Reddy PAN, Kenney SC, Lieberman PM, Salvino JM. Development of a novel inducer for EBV lytic therapy. Bioorganic & Medicinal Chemistry Letters. PMID 31255485 DOI: 10.1016/J.Bmcl.2019.06.034  0.332
2019 Tutton S, Deng Z, Gulve N, Vladimirova O, Beishline K, Wiedmer A, Murphy M, Lieberman PM. Elevated telomere dysfunction in cells containing the African-centric Pro47Ser cancer-risk variant of TP53. Oncotarget. 10: 3581-3591. PMID 31217894 DOI: 10.18632/Oncotarget.26980  0.812
2019 Malecka KA, Dheekollu J, Deakyne JS, Wiedmer A, Ramirez UD, Lieberman PM, Messick TE. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication. Journal of Virology. PMID 31142669 DOI: 10.1128/Jvi.00487-19  0.594
2019 Veglia F, Tyurin VA, Blasi M, De Leo A, Kossenkov AV, Donthireddy L, To TKJ, Schug Z, Basu S, Wang F, Ricciotti E, DiRusso C, Murphy ME, Vonderheide RH, Lieberman PM, et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. PMID 30996346 DOI: 10.1038/S41586-019-1118-2  0.318
2019 Messick TE, Smith GR, Soldan SS, McDonnell ME, Deakyne JS, Malecka KA, Tolvinski L, van den Heuvel APJ, Gu BW, Cassel JA, Tran DH, Wassermann BR, Zhang Y, Velvadapu V, Zartler ER, ... ... Lieberman PM, et al. Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth. Science Translational Medicine. 11. PMID 30842315 DOI: 10.1126/Scitranslmed.Aau5612  0.53
2019 Shastrula PK, Sierra I, Deng Z, Keeney F, Hayden JE, Lieberman PM, Janicki SM. PML is recruited to heterochromatin during S phase and represses DAXX-mediated histone H3.3 chromatin assembly. Journal of Cell Science. PMID 30796101 DOI: 10.1242/Jcs.220970  0.407
2019 De Leo A, Deng Z, Vladimirova O, Chen HS, Dheekollu J, Calderon A, Myers KA, Hayden J, Keeney F, Kaufer BB, Yuan Y, Robertson E, Lieberman PM. LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency. Plos Pathogens. 15: e1007489. PMID 30682185 DOI: 10.1371/Journal.Ppat.1007489  0.561
2018 Reyes-Uribe P, Adrianzen-Ruesta MP, Deng Z, Echevarria-Vargas I, Mender I, Saheb S, Liu Q, Altieri DC, Murphy ME, Shay JW, Lieberman PM, Villanueva J. Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma. Oncogene. PMID 29695835 DOI: 10.1038/S41388-018-0247-7  0.309
2018 AlQarni S, Al-Sheikh Y, Campbell D, Drotar M, Hannigan A, Boyle S, Herzyk P, Kossenkov A, Armfield K, Jamieson L, Bailo M, Lieberman PM, Tsimbouri P, Wilson JB. Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2. Oncogene. PMID 29691476 DOI: 10.1038/S41388-018-0147-X  0.4
2018 Wanat JJ, Logsdon GA, Driskill JH, Deng Z, Lieberman PM, Johnson FB. TERRA and the histone methyltransferase Dot1 cooperate to regulate senescence in budding yeast. Plos One. 13: e0195698. PMID 29649255 DOI: 10.1371/Journal.Pone.0195698  0.428
2018 Mawhinney MT, Liu R, Lu F, Maksimoska J, Damico K, Marmorstein R, Lieberman PM, Urbanc B. CTCF-Induced Circular DNA Complexes Observed by Atomic Force Microscopy. Journal of Molecular Biology. PMID 29409905 DOI: 10.1016/J.Jmb.2018.01.012  0.487
2018 Tso FY, Kossenkov AV, Lidenge SJ, Ngalamika O, Ngowi JR, Mwaiselage J, Wickramasinghe J, Kwon EH, West JT, Lieberman PM, Wood C. RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism. Plos Pathogens. 14: e1006844. PMID 29352292 DOI: 10.1371/Journal.Ppat.1006844  0.372
2017 Beishline K, Vladimirova O, Tutton S, Wang Z, Deng Z, Lieberman PM. CTCF driven TERRA transcription facilitates completion of telomere DNA replication. Nature Communications. 8: 2114. PMID 29235471 DOI: 10.1038/S41467-017-02212-W  0.837
2017 Shastrula PK, Rice CT, Wang Z, Lieberman PM, Skordalakes E. Structural and functional analysis of an OB-fold in human Ctc1 implicated in telomere maintenance and bone marrow syndromes. Nucleic Acids Research. PMID 29228254 DOI: 10.1093/Nar/Gkx1213  0.438
2017 Tutton S, Lieberman PM. A role for p53 in telomere protection. Molecular & Cellular Oncology. 4: e1143078. PMID 29209637 DOI: 10.1080/23723556.2016.1143078  0.482
2017 De Leo A, Chen HS, Hu CA, Lieberman PM. Deregulation of KSHV latency conformation by ER-stress and caspase-dependent RAD21-cleavage. Plos Pathogens. 13: e1006596. PMID 28854249 DOI: 10.1371/Journal.Ppat.1006596  0.435
2017 Lu F, Wiedmer A, Martin KA, Wickramasinghe PJMS, Kossenkov AV, Lieberman PM. Coordinate Regulation of TET2 and EBNA2 Control DNA Methylation State of Latent Epstein-Barr Virus. Journal of Virology. PMID 28794029 DOI: 10.1128/Jvi.00804-17  0.542
2017 Wang Z, Deng Z, Tutton S, Lieberman PM. The Telomeric Response to Viral Infection. Viruses. 9. PMID 28792463 DOI: 10.3390/V9080218  0.474
2017 Choi SJ, Shin YS, Kang BW, Kim JG, Won KJ, Lieberman PM, Cho H, Kang H. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma. Archives of Pharmacal Research. PMID 28779374 DOI: 10.1007/S12272-017-0939-5  0.489
2017 Tikhmyanova N, Tutton S, Martin KA, Lu F, Kossenkov AV, Paparoidamis N, Kenney S, Salvino JM, Lieberman PM. Small molecule perturbation of the CAND1-Cullin1-ubiquitin cycle stabilizes p53 and triggers Epstein-Barr virus reactivation. Plos Pathogens. 13: e1006517. PMID 28715492 DOI: 10.1371/Journal.Ppat.1006517  0.383
2017 Deakyne JS, Malecka K, Messick TE, Lieberman PM. Structure and functional basis for an EBNA1 hexameric ring in Epstein-Barr Virus episome maintenance. Journal of Virology. PMID 28701406 DOI: 10.1128/Jvi.01046-17  0.557
2017 Chen HS, De Leo A, Wang Z, Kerekovic A, Hills R, Lieberman PM. BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency. Plos Pathogens. 13: e1006100. PMID 28107481 DOI: 10.1371/Journal.Ppat.1006100  0.534
2017 Dheekollu J, Malecka K, Wiedmer A, Delecluse HJ, Chiang AK, Altieri DC, Messick TE, Lieberman PM. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency. Oncotarget. PMID 28077791 DOI: 10.18632/Oncotarget.14540  0.542
2017 Lang F, Li X, Vladimirova O, Hu B, Chen G, Xiao Y, Singh V, Lu D, Li L, Han H, Wickramasinghe JM, Smith ST, Zheng C, Li Q, Lieberman PM, et al. CTCF interacts with the lytic HSV-1 genome to promote viral transcription. Scientific Reports. 7: 39861. PMID 28045091 DOI: 10.1038/Srep39861  0.532
2017 Messick TE, Soldan SS, Deakyne J, Lieberman PM. Development of a small molecule drug for EBV-associated gastric cancers. Journal of Clinical Oncology. 35: 63-63. DOI: 10.1200/Jco.2017.35.4_Suppl.63  0.394
2016 Arsenault PR, Song D, Bergkamp M, Ravaschiere AM, Navalsky BE, Lieberman PM, Lee FS. Identification of Small Molecule PHD2 Zinc Finger Inhibitors that Activate Hypoxia Inducible Factor. Chembiochem : a European Journal of Chemical Biology. PMID 27770548 DOI: 10.1002/Cbic.201600493  0.348
2016 Huang H, Deng Z, Vladimirova O, Wiedmer A, Lu F, Lieberman PM, Patel DJ. Structural basis underlying viral hijacking of a histone chaperone complex. Nature Communications. 7: 12707. PMID 27581705 DOI: 10.1038/Ncomms12707  0.429
2016 Lieberman PM. Retrotransposon-derived p53 binding sites enhance telomere maintenance and genome protection. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. PMID 27539745 DOI: 10.1002/Bies.201600078  0.484
2016 Lieberman PM. Getting Back to the Basics of Translational Research. Plos Pathogens. 12: e1005534. PMID 27442241 DOI: 10.1371/Journal.Ppat.1005534  0.373
2016 Wang Z, Lieberman PM. The crosstalk of telomere dysfunction and inflammation through cell-free TERRA containing exosomes. Rna Biology. 0. PMID 27351774 DOI: 10.1080/15476286.2016.1203503  0.421
2016 Lieberman PM. Epigenetics and Genetics of Viral Latency. Cell Host & Microbe. 19: 619-28. PMID 27173930 DOI: 10.1016/J.Chom.2016.04.008  0.388
2016 Gianti E, Messick TE, Lieberman PM, Zauhar RJ. Computational analysis of EBNA1 "druggability" suggests novel insights for Epstein-Barr virus inhibitor design. Journal of Computer-Aided Molecular Design. PMID 27048620 DOI: 10.1007/S10822-016-9899-Y  0.485
2016 Dheekollu J, Wiedmer A, Sentana-Lledo D, Cassel J, Messick T, Lieberman PM. HCF1 and OCT2 Cooperate with EBNA1 to Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus. Journal of Virology. PMID 27009953 DOI: 10.1128/Jvi.00239-16  0.507
2016 Lu F, Chen HS, Kossenkov AV, DeWispeleare K, Won KJ, Lieberman PM. EBNA2 Drives Formation of New Chromosome Binding Sites and Target Genes for B-Cell Master Regulatory Transcription Factors RBP-jκ and EBF1. Plos Pathogens. 12: e1005339. PMID 26752713 DOI: 10.1371/Journal.Ppat.1005339  0.473
2015 Tutton S, Azzam GA, Stong N, Vladimirova O, Wiedmer A, Monteith JA, Beishline K, Wang Z, Deng Z, Riethman H, McMahon SB, Murphy M, Lieberman PM. Subtelomeric p53 binding prevents accumulation of DNA damage at human telomeres. The Embo Journal. PMID 26658110 DOI: 10.15252/Embj.201490880  0.816
2015 Wang Z, Deng Z, Dahmane N, Tsai K, Wang P, Williams DR, Kossenkov AV, Showe LC, Zhang R, Huang Q, Conejo-Garcia JR, Lieberman PM. Telomeric repeat-containing RNA (TERRA) constitutes a nucleoprotein component of extracellular inflammatory exosomes. Proceedings of the National Academy of Sciences of the United States of America. 112: E6293-E6300. PMID 26578789 DOI: 10.1073/Pnas.1505962112  0.589
2015 Tempera I, De Leo A, Kossenkov A, Cesaroni M, Song H, Dawaney N, Showe L, Lu F, Wikramasinghe P, Lieberman PM. Identification of MEF2B, EBF1, and IL6R as direct gene targets of EBNA1 critical for EBV-infected B-lymphocyte survival. Journal of Virology. PMID 26468528 DOI: 10.1128/Jvi.02318-15  0.489
2015 Lieberman PM. Chromatin Structure of Epstein-Barr Virus Latent Episomes. Current Topics in Microbiology and Immunology. 390: 71-102. PMID 26424644 DOI: 10.1007/978-3-319-22822-8_5  0.464
2015 De Leo A, Colavita F, Ciccosanti F, Fimia GM, Lieberman PM, Mattia E. Inhibition of autophagy in EBV-positive Burkitt's lymphoma cells enhances EBV lytic genes expression and replication. Cell Death & Disease. 6: e1876. PMID 26335716 DOI: 10.1038/Cddis.2015.156  0.463
2015 Tsai K, Messick TE, Lieberman PM. Disruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzyme. Current Opinion in Virology. 14: 30-40. PMID 26256000 DOI: 10.1016/J.Coviro.2015.07.008  0.577
2015 Leo AD, Colavita F, Ciccosanti F, Fimia GM, Lieberman P, Mattia E. Abstract 4568: Inhibition of autophagy in EBV-positive Burkitt's lymphoma cells enhances EBV lytic genes expression and replication Cancer Research. 75: 4568-4568. DOI: 10.1158/1538-7445.Am2015-4568  0.461
2014 Deng Z, Kim ET, Vladimirova O, Dheekollu J, Wang Z, Newhart A, Liu D, Myers JL, Hensley SE, Moffat J, Janicki SM, Fraser NW, Knipe DM, Weitzman MD, Lieberman PM. HSV-1 remodels host telomeres to facilitate viral replication. Cell Reports. 9: 2263-78. PMID 25497088 DOI: 10.1016/J.Celrep.2014.11.019  0.592
2014 Tsai K, Chan L, Gibeault R, Conn K, Dheekollu J, Domsic J, Marmorstein R, Schang LM, Lieberman PM. Viral reprogramming of the Daxx histone H3.3 chaperone during early Epstein-Barr virus infection. Journal of Virology. 88: 14350-63. PMID 25275136 DOI: 10.1128/Jvi.01895-14  0.608
2014 Martínez FP, Cruz R, Lu F, Plasschaert R, Deng Z, Rivera-Molina YA, Bartolomei MS, Lieberman PM, Tang Q. CTCF binding to the first intron of the major immediate early (MIE) gene of human cytomegalovirus (HCMV) negatively regulates MIE gene expression and HCMV replication. Journal of Virology. 88: 7389-401. PMID 24741094 DOI: 10.1128/Jvi.00845-14  0.515
2014 Stong N, Deng Z, Gupta R, Hu S, Paul S, Weiner AK, Eichler EE, Graves T, Fronick CC, Courtney L, Wilson RK, Lieberman PM, Davuluri RV, Riethman H. Subtelomeric CTCF and cohesin binding site organization using improved subtelomere assemblies and a novel annotation pipeline. Genome Research. 24: 1039-50. PMID 24676094 DOI: 10.1101/Gr.166983.113  0.399
2014 Lieberman PM. Virology. Epstein-Barr virus turns 50. Science (New York, N.Y.). 343: 1323-5. PMID 24653027 DOI: 10.1126/Science.1252786  0.369
2014 Tempera I, Lieberman PM. Epigenetic regulation of EBV persistence and oncogenesis. Seminars in Cancer Biology. 26: 22-9. PMID 24468737 DOI: 10.1016/J.Semcancer.2014.01.003  0.487
2014 Lu F, Tempera I, Lee HT, Dewispelaere K, Lieberman PM. EBNA1 binding and epigenetic regulation of gastrokine tumor suppressor genes in gastric carcinoma cells. Virology Journal. 11: 12. PMID 24460791 DOI: 10.1186/1743-422X-11-12  0.468
2014 Chen HS, Martin KA, Lu F, Lupey LN, Mueller JM, Lieberman PM, Tempera I. Epigenetic deregulation of the LMP1/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding site. Journal of Virology. 88: 1703-13. PMID 24257606 DOI: 10.1128/Jvi.02209-13  0.569
2014 Tikhmyanova N, Schultz DC, Lee T, Salvino JM, Lieberman PM. Identification of a new class of small molecules that efficiently reactivate latent Epstein-Barr Virus. Acs Chemical Biology. 9: 785-95. PMID 24028149 DOI: 10.1021/Cb4006326  0.353
2014 Plasschaert RN, Vigneau S, Tempera I, Gupta R, Maksimoska J, Everett L, Davuluri R, Marmorstein R, Lieberman PM, Schultz D, Hannenhalli S, Bartolomei MS. CTCF binding site sequence differences are associated with unique regulatory and functional trends during embryonic stem cell differentiation Nucleic Acids Research. 42: 7487-7487. DOI: 10.1093/Nar/Gku470  0.322
2013 Lieberman PM. Keeping it quiet: chromatin control of gammaherpesvirus latency. Nature Reviews. Microbiology. 11: 863-75. PMID 24192651 DOI: 10.1038/Nrmicro3135  0.506
2013 Oyama T, Sasagawa S, Takeda S, Hess RA, Lieberman PM, Cheng EH, Hsieh JJ. Cleavage of TFIIA by Taspase1 activates TRF2-specified mammalian male germ cell programs. Developmental Cell. 27: 188-200. PMID 24176642 DOI: 10.1016/J.Devcel.2013.09.025  0.378
2013 Son M, Lee M, Sung GH, Lee T, Shin YS, Cho H, Lieberman PM, Kang H. Bioactive activities of natural products against herpesvirus infection. Journal of Microbiology (Seoul, Korea). 51: 545-51. PMID 24173639 DOI: 10.1007/S12275-013-3450-9  0.354
2013 Domsic JF, Chen HS, Lu F, Marmorstein R, Lieberman PM. Molecular basis for oligomeric-DNA binding and episome maintenance by KSHV LANA. Plos Pathogens. 9: e1003672. PMID 24146617 DOI: 10.1371/Journal.Ppat.1003672  0.536
2013 Deng Z, Glousker G, Molczan A, Fox AJ, Lamm N, Dheekollu J, Weizman OE, Schertzer M, Wang Z, Vladimirova O, Schug J, Aker M, Londoño-Vallejo A, Kaestner KH, Lieberman PM, et al. Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome. Proceedings of the National Academy of Sciences of the United States of America. 110: E3408-16. PMID 23959892 DOI: 10.1073/Pnas.1300600110  0.432
2013 Leskowitz RM, Zhou XY, Villinger F, Fogg MH, Kaur A, Lieberman PM, Wang F, Ertl HC. CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques. Journal of Virology. 87: 8351-62. PMID 23698300 DOI: 10.1128/Jvi.00852-13  0.319
2013 Chen HS, Lu F, Lieberman PM. Epigenetic regulation of EBV and KSHV latency. Current Opinion in Virology. 3: 251-9. PMID 23601957 DOI: 10.1016/J.Coviro.2013.03.004  0.47
2013 Arvey A, Tempera I, Lieberman PM. Interpreting the Epstein-Barr Virus (EBV) epigenome using high-throughput data. Viruses. 5: 1042-54. PMID 23549386 DOI: 10.3390/V5041042  0.499
2013 Dheekollu J, Chen HS, Kaye KM, Lieberman PM. Timeless-dependent DNA replication-coupled recombination promotes Kaposi's Sarcoma-associated herpesvirus episome maintenance and terminal repeat stability. Journal of Virology. 87: 3699-709. PMID 23325691 DOI: 10.1128/Jvi.02211-12  0.593
2013 Knipe DM, Lieberman PM, Jung JU, McBride AA, Morris KV, Ott M, Margolis D, Nieto A, Nevels M, Parks RJ, Kristie TM. Snapshots: chromatin control of viral infection. Virology. 435: 141-56. PMID 23217624 DOI: 10.1016/J.Virol.2012.09.023  0.366
2013 Kang H, Cho H, Sung GH, Lieberman PM. CTCF regulates Kaposi's sarcoma-associated herpesvirus latency transcription by nucleosome displacement and RNA polymerase programming. Journal of Virology. 87: 1789-99. PMID 23192870 DOI: 10.1128/Jvi.02283-12  0.492
2012 Deng Z, Wang Z, Lieberman PM. Telomeres and viruses: common themes of genome maintenance. Frontiers in Oncology. 2: 201. PMID 23293769 DOI: 10.3389/Fonc.2012.00201  0.447
2012 Deng Z, Wang Z, Stong N, Plasschaert R, Moczan A, Chen HS, Hu S, Wikramasinghe P, Davuluri RV, Bartolomei MS, Riethman H, Lieberman PM. A role for CTCF and cohesin in subtelomere chromatin organization, TERRA transcription, and telomere end protection. The Embo Journal. 31: 4165-78. PMID 23010778 DOI: 10.1038/Emboj.2012.266  0.552
2012 Arvey A, Tempera I, Tsai K, Chen HS, Tikhmyanova N, Klichinsky M, Leslie C, Lieberman PM. An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host & Microbe. 12: 233-45. PMID 22901543 DOI: 10.1016/J.Chom.2012.06.008  0.671
2012 Chen HS, Wikramasinghe P, Showe L, Lieberman PM. Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency. Journal of Virology. 86: 9454-64. PMID 22740398 DOI: 10.1128/Jvi.00787-12  0.522
2012 Leman AR, Dheekollu J, Deng Z, Lee SW, Das MM, Lieberman PM, Noguchi E. Timeless preserves telomere length by promoting efficient DNA replication through human telomeres. Cell Cycle (Georgetown, Tex.). 11: 2337-47. PMID 22672906 DOI: 10.4161/Cc.20810  0.542
2012 Deng Z, Wang Z, Xiang C, Molczan A, Baubet V, Conejo-Garcia J, Xu X, Lieberman PM, Dahmane N. Formation of telomeric repeat-containing RNA (TERRA) foci in highly proliferating mouse cerebellar neuronal progenitors and medulloblastoma. Journal of Cell Science. 125: 4383-94. PMID 22641694 DOI: 10.1242/Jcs.108118  0.429
2012 Lu F, Tsai K, Chen HS, Wikramasinghe P, Davuluri RV, Showe L, Domsic J, Marmorstein R, Lieberman PM. Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA. Journal of Virology. 86: 5752-62. PMID 22419807 DOI: 10.1128/Jvi.07216-11  0.651
2011 Tsai K, Thikmyanova N, Wojcechowskyj JA, Delecluse HJ, Lieberman PM. EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription. Plos Pathogens. 7: e1002376. PMID 22102817 DOI: 10.1371/Journal.Ppat.1002376  0.608
2011 Kang H, Lieberman PM. Mechanism of glycyrrhizic acid inhibition of Kaposi's sarcoma-associated herpesvirus: disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion. Journal of Virology. 85: 11159-69. PMID 21880767 DOI: 10.1128/Jvi.00720-11  0.427
2011 Kang H, Wiedmer A, Yuan Y, Robertson E, Lieberman PM. Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation. Plos Pathogens. 7: e1002140. PMID 21876668 DOI: 10.1371/Journal.Ppat.1002140  0.494
2011 Tempera I, Klichinsky M, Lieberman PM. EBV latency types adopt alternative chromatin conformations. Plos Pathogens. 7: e1002180. PMID 21829357 DOI: 10.1371/Journal.Ppat.1002180  0.43
2011 Dheekollu J, Wiedmer A, Hayden J, Speicher D, Gotter AL, Yen T, Lieberman PM. Timeless links replication termination to mitotic kinase activation. Plos One. 6: e19596. PMID 21573113 DOI: 10.1371/Journal.Pone.0019596  0.484
2011 Dheekollu J, Lieberman PM. The replisome pausing factor Timeless is required for episomal maintenance of latent Epstein-Barr virus. Journal of Virology. 85: 5853-63. PMID 21490103 DOI: 10.1128/Jvi.02425-10  0.597
2011 Rennekamp AJ, Lieberman PM. Initiation of Epstein-Barr virus lytic replication requires transcription and the formation of a stable RNA-DNA hybrid molecule at OriLyt. Journal of Virology. 85: 2837-50. PMID 21191028 DOI: 10.1128/Jvi.02175-10  0.815
2010 Li N, Thompson S, Jiang H, Lieberman PM, Luo C. Development of drugs for Epstein-Barr virus using high-throughput in silico virtual screening. Expert Opinion On Drug Discovery. 5: 1189-203. PMID 22822721 DOI: 10.1517/17460441.2010.524640  0.34
2010 Rennekamp AJ, Lieberman PM. Initiation of lytic DNA replication in Epstein-Barr virus: search for a common family mechanism. Future Virology. 5: 65-83. PMID 22468146 DOI: 10.2217/Fvl.09.69  0.788
2010 Thompson S, Messick T, Schultz DC, Reichman M, Lieberman PM. Development of a high-throughput screen for inhibitors of Epstein-Barr virus EBNA1. Journal of Biomolecular Screening. 15: 1107-15. PMID 20930215 DOI: 10.1177/1087057110379154  0.507
2010 Lu F, Wikramasinghe P, Norseen J, Tsai K, Wang P, Showe L, Davuluri RV, Lieberman PM. Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1). Virology Journal. 7: 262. PMID 20929547 DOI: 10.1186/1743-422X-7-262  0.817
2010 Tempera I, Wiedmer A, Dheekollu J, Lieberman PM. CTCF prevents the epigenetic drift of EBV latency promoter Qp. Plos Pathogens. 6: e1001048. PMID 20730088 DOI: 10.1371/Journal.Ppat.1001048  0.514
2010 Iizasa H, Wulff BE, Alla NR, Maragkakis M, Megraw M, Hatzigeorgiou A, Iwakiri D, Takada K, Wiedmer A, Showe L, Lieberman P, Nishikura K. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. The Journal of Biological Chemistry. 285: 33358-70. PMID 20716523 DOI: 10.1074/Jbc.M110.138362  0.314
2010 Hou Z, Peng H, White DE, Wang P, Lieberman PM, Halazonetis T, Rauscher FJ. 14-3-3 Binding sites in the snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal differentiation Cancer Research. 70: 4385-4393. PMID 20501852 DOI: 10.1158/0008-5472.Can-10-0070  0.454
2010 Rennekamp AJ, Wang P, Lieberman PM. Evidence for DNA hairpin recognition by Zta at the Epstein-Barr virus origin of lytic replication. Journal of Virology. 84: 7073-82. PMID 20444899 DOI: 10.1128/Jvi.02666-09  0.82
2010 Li N, Thompson S, Schultz DC, Zhu W, Jiang H, Luo C, Lieberman PM. Discovery of selective inhibitors against EBNA1 via high throughput in silico virtual screening. Plos One. 5: e10126. PMID 20405039 DOI: 10.1371/Journal.Pone.0010126  0.485
2010 Bedelbaeva K, Snyder A, Gourevitch D, Clark L, Zhang XM, Leferovich J, Cheverud JM, Lieberman P, Heber-Katz E. Lack of p21 expression links cell cycle control and appendage regeneration in mice. Proceedings of the National Academy of Sciences of the United States of America. 107: 5845-50. PMID 20231440 DOI: 10.1073/Pnas.1000830107  0.353
2010 Lieberman PM. Chromatin in viral gene regulation. Preface. Biochimica Et Biophysica Acta. 1799: 181. PMID 20227658 DOI: 10.1016/J.Bbagrm.2010.02.002  0.413
2010 Tempera I, Deng Z, Atanasiu C, Chen CJ, D'Erme M, Lieberman PM. Regulation of Epstein-Barr virus OriP replication by poly(ADP-ribose) polymerase 1. Journal of Virology. 84: 4988-97. PMID 20219917 DOI: 10.1128/Jvi.02333-09  0.631
2010 Zhou J, Deng Z, Norseen J, Lieberman PM. Regulation of Epstein-Barr virus origin of plasmid replication (OriP) by the S-phase checkpoint kinase Chk2. Journal of Virology. 84: 4979-87. PMID 20200249 DOI: 10.1128/Jvi.01300-09  0.837
2010 Lu F, Stedman W, Yousef M, Renne R, Lieberman PM. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. Journal of Virology. 84: 2697-706. PMID 20071580 DOI: 10.1128/Jvi.01997-09  0.445
2010 Deng Z, Campbell AE, Lieberman PM. TERRA, CpG methylation and telomere heterochromatin: lessons from ICF syndrome cells. Cell Cycle (Georgetown, Tex.). 9: 69-74. PMID 20016274 DOI: 10.4161/Cc.9.1.10358  0.4
2010 Tempera I, Lieberman PM. Chromatin organization of gammaherpesvirus latent genomes. Biochimica Et Biophysica Acta. 1799: 236-45. PMID 19853673 DOI: 10.1016/J.Bbagrm.2009.10.004  0.535
2009 Deng Z, Norseen J, Wiedmer A, Riethman H, Lieberman PM. TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Molecular Cell. 35: 403-13. PMID 19716786 DOI: 10.1016/J.Molcel.2009.06.025  0.811
2009 Norseen J, Johnson FB, Lieberman PM. Role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment. Journal of Virology. 83: 10336-46. PMID 19656898 DOI: 10.1128/Jvi.00747-09  0.825
2009 Wang P, Rennekamp AJ, Yuan Y, Lieberman PM. Topoisomerase I and RecQL1 function in Epstein-Barr virus lytic reactivation. Journal of Virology. 83: 8090-8. PMID 19494003 DOI: 10.1128/Jvi.02379-08  0.815
2009 Kang H, Lieberman PM. Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions. Journal of Virology. 83: 6199-210. PMID 19369356 DOI: 10.1128/Jvi.00052-09  0.498
2009 Snyder AR, Zhou J, Deng Z, Lieberman PM. Therapeutic doses of hydroxyurea cause telomere dysfunction and reduce TRF2 binding to telomeres. Cancer Biology & Therapy. 8: 1136-45. PMID 19363303 DOI: 10.4161/Cbt.8.12.8446  0.528
2009 Zhou J, Snyder AR, Lieberman PM. Epstein-Barr virus episome stability is coupled to a delay in replication timing. Journal of Virology. 83: 2154-62. PMID 19073720 DOI: 10.1128/Jvi.02115-08  0.549
2008 Norseen J, Thomae A, Sridharan V, Aiyar A, Schepers A, Lieberman PM. RNA-dependent recruitment of the origin recognition complex. The Embo Journal. 27: 3024-35. PMID 18946490 DOI: 10.1038/Emboj.2008.221  0.824
2008 Lu F, Weidmer A, Liu CG, Volinia S, Croce CM, Lieberman PM. Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. Journal of Virology. 82: 10436-43. PMID 18753206 DOI: 10.1128/Jvi.00752-08  0.333
2008 Lieberman PM. Chromatin organization and virus gene expression. Journal of Cellular Physiology. 216: 295-302. PMID 18314879 DOI: 10.1002/Jcp.21421  0.532
2008 Wiedmer A, Wang P, Zhou J, Rennekamp AJ, Tiranti V, Zeviani M, Lieberman PM. Epstein-Barr virus immediate-early protein Zta co-opts mitochondrial single-stranded DNA binding protein to promote viral and inhibit mitochondrial DNA replication. Journal of Virology. 82: 4647-55. PMID 18305033 DOI: 10.1128/Jvi.02198-07  0.821
2008 Stedman W, Kang H, Lin S, Kissil JL, Bartolomei MS, Lieberman PM. Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. The Embo Journal. 27: 654-66. PMID 18219272 DOI: 10.1038/Emboj.2008.1  0.427
2008 Chau CM, Deng Z, Kang H, Lieberman PM. Cell cycle association of the retinoblastoma protein Rb and the histone demethylase LSD1 with the Epstein-Barr virus latency promoter Cp. Journal of Virology. 82: 3428-37. PMID 18216119 DOI: 10.1128/Jvi.01412-07  0.545
2007 Dheekollu J, Deng Z, Wiedmer A, Weitzman MD, Lieberman PM. A role for MRE11, NBS1, and recombination junctions in replication and stable maintenance of EBV episomes. Plos One. 2: e1257. PMID 18040525 DOI: 10.1371/Journal.Pone.0001257  0.538
2007 Deng Z, Dheekollu J, Broccoli D, Dutta A, Lieberman PM. The origin recognition complex localizes to telomere repeats and prevents telomere-circle formation. Current Biology : Cb. 17: 1989-95. PMID 18006317 DOI: 10.1016/J.Cub.2007.10.054  0.514
2007 Day L, Chau CM, Nebozhyn M, Rennekamp AJ, Showe M, Lieberman PM. Chromatin profiling of Epstein-Barr virus latency control region. Journal of Virology. 81: 6389-401. PMID 17409162 DOI: 10.1128/Jvi.02172-06  0.797
2007 Lieberman PM, Hu J, Renne R. Gammaherpesvirus maintenance and replication during latency Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. 379-402. DOI: 10.1017/CBO9780511545313.025  0.321
2006 Wang P, Day L, Lieberman PM. Multivalent sequence recognition by Epstein-Barr virus Zta requires cysteine 171 and an extension of the canonical B-ZIP domain. Journal of Virology. 80: 10942-9. PMID 16971443 DOI: 10.1128/Jvi.00907-06  0.521
2006 Atanasiu C, Deng Z, Wiedmer A, Norseen J, Lieberman PM. ORC binding to TRF2 stimulates OriP replication. Embo Reports. 7: 716-21. PMID 16799465 DOI: 10.1038/Sj.Embor.7400730  0.832
2006 Chau CM, Zhang XY, McMahon SB, Lieberman PM. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. Journal of Virology. 80: 5723-32. PMID 16731911 DOI: 10.1128/Jvi.00025-06  0.489
2006 Lu F, Day L, Gao SJ, Lieberman PM. Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. Journal of Virology. 80: 5273-82. PMID 16699007 DOI: 10.1128/Jvi.02541-05  0.504
2006 Lieberman PM. Chromatin regulation of virus infection. Trends in Microbiology. 14: 132-40. PMID 16458005 DOI: 10.1016/J.Tim.2006.01.001  0.525
2005 Wang P, Day L, Dheekollu J, Lieberman PM. A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication. Journal of Virology. 79: 13298-309. PMID 16227252 DOI: 10.1128/Jvi.79.21.13298-13309.2005  0.568
2005 Lu F, Day L, Lieberman PM. Kaposi's sarcoma-associated herpesvirus virion-induced transcription activation of the ORF50 immediate-early promoter. Journal of Virology. 79: 13180-5. PMID 16189019 DOI: 10.1128/Jvi.79.20.13180-13185.2005  0.441
2005 Zhou J, Chau C, Deng Z, Stedman W, Lieberman PM. Epigenetic control of replication origins. Cell Cycle (Georgetown, Tex.). 4: 889-92. PMID 15917669 DOI: 10.4161/Cc.4.7.1823  0.525
2005 Deng Z, Atanasiu C, Zhao K, Marmorstein R, Sbodio JI, Chi NW, Lieberman PM. Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1. Journal of Virology. 79: 4640-50. PMID 15795250 DOI: 10.1128/Jvi.79.8.4640-4650.2005  0.607
2005 Zhou J, Chau CM, Deng Z, Shiekhattar R, Spindler MP, Schepers A, Lieberman PM. Cell cycle regulation of chromatin at an origin of DNA replication. The Embo Journal. 24: 1406-17. PMID 15775975 DOI: 10.1038/Sj.Emboj.7600609  0.497
2005 Atanasiu C, Lezina L, Lieberman PM. DNA affinity purification of Epstein-Barr virus OriP-binding proteins. Methods in Molecular Biology (Clifton, N.J.). 292: 267-76. PMID 15507714 DOI: 10.1385/1-59259-848-X:267  0.527
2004 Stedman W, Deng Z, Lu F, Lieberman PM. ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. Journal of Virology. 78: 12566-75. PMID 15507644 DOI: 10.1128/Jvi.78.22.12566-12575.2004  0.586
2004 Chau CM, Lieberman PM. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. Journal of Virology. 78: 12308-19. PMID 15507618 DOI: 10.1128/Jvi.78.22.12308-12319.2004  0.475
2004 Lavens S, Faust EA, Lu F, Jacob M, Leta M, Lieberman PM, Puré E. Identification of protein tyrosine kinases required for B-cell- receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter. Journal of Virology. 78: 8543-51. PMID 15280463 DOI: 10.1128/Jvi.78.16.8543-8551.2004  0.39
2003 Deng Z, Atanasiu C, Burg JS, Broccoli D, Lieberman PM. Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP. Journal of Virology. 77: 11992-2001. PMID 14581536 DOI: 10.1128/Jvi.77.22.11992-12001.2003  0.609
2003 Lu F, Zhou J, Wiedmer A, Madden K, Yuan Y, Lieberman PM. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. Journal of Virology. 77: 11425-35. PMID 14557628 DOI: 10.1128/Jvi.77.21.11425-11435.2003  0.456
2003 Deng Z, Chen CJ, Chamberlin M, Lu F, Blobel GA, Speicher D, Cirillo LA, Zaret KS, Lieberman PM. The CBP bromodomain and nucleosome targeting are required for Zta-directed nucleosome acetylation and transcription activation. Molecular and Cellular Biology. 23: 2633-44. PMID 12665567 DOI: 10.1128/Mcb.23.8.2633-2644.2003  0.496
2002 Deng Z, Lezina L, Chen CJ, Shtivelband S, So W, Lieberman PM. Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication. Molecular Cell. 9: 493-503. PMID 11931758 DOI: 10.1016/S1097-2765(02)00476-8  0.581
2001 Deng Z, Chen CJ, Zerby D, Delecluse HJ, Lieberman PM. Identification of acidic and aromatic residues in the Zta activation domain essential for Epstein-Barr virus reactivation Journal of Virology. 75: 10334-10347. PMID 11581402 DOI: 10.1128/Jvi.75.21.10334-10347.2001  0.452
2001 Solow S, Salunek M, Ryan R, Lieberman PM. TAFII 250 Phosphorylates Human Transcription Factor IIA on Serine Residues Important for TBP Binding and Transcription Activity Journal of Biological Chemistry. 276: 15886-15892. PMID 11278496 DOI: 10.1074/Jbc.M009385200  0.387
2001 Chen CJ, Deng Z, Kim AY, Blobel GA, Lieberman PM. Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators Molecular and Cellular Biology. 21: 476-487. PMID 11134336 DOI: 10.1128/Mcb.21.2.476-487.2001  0.474
2000 Bell P, Lieberman PM, Maul GG. Lytic but not latent replication of Epstein-Barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins Journal of Virology. 74: 11800-11810. PMID 11090180 DOI: 10.1128/Jvi.74.24.11800-11810.2000  0.522
2000 Ozer J, Moore PA, Lieberman PM. A testis-specific transcription factor IIA (TFIIAtau) stimulates TATA-binding protein-DNA binding and transcription activation. The Journal of Biological Chemistry. 275: 122-8. PMID 10617594 DOI: 10.1074/jbc.275.1.122  0.418
2000 Belotserkovskaya R, Sterner DE, Deng M, Sayre MH, Lieberman PM, Berger SL. Inhibition of TATA-binding protein function by SAGA subunits Spt3 and Spt8 at Gcn4-activated promoters Molecular and Cellular Biology. 20: 634-647. PMID 10611242 DOI: 10.1128/Mcb.20.2.634-647.2000  0.466
1999 Moore PA, Ozer J, Salunek M, Jan G, Zerby D, Campbell S, Lieberman PM. A human TATA binding protein-related protein with altered DNA binding specificity inhibits transcription from multiple promoters and activators. Molecular and Cellular Biology. 19: 7610-20. PMID 10523649 DOI: 10.1128/Mcb.19.11.7610  0.523
1999 Solow SP, Lezina L, Lieberman PM. Phosphorylation of TFIIA stimulates TATA binding protein-TATA interaction and contributes to maximal transcription and viability in yeast Molecular and Cellular Biology. 19: 2846-2852. PMID 10082550 DOI: 10.1128/Mcb.19.4.2846  0.48
1999 Zerby D, Chen CJ, Poon E, Lee D, Shiekhattar R, Lieberman PM. The amino-terminal C/H1 domain of CREB binding protein mediates Zta transcriptional activation of latent Epstein-Barr virus Molecular and Cellular Biology. 19: 1617-1626. PMID 10022850 DOI: 10.1128/Mcb.19.3.1617  0.44
1998 Damania B, Lieberman P, Alwine JC. Simian virus 40 large T antigen stabilizes the TATA-binding protein- TFIIA complex on the TATA element Molecular and Cellular Biology. 18: 3926-3935. PMID 9632777 DOI: 10.1128/Mcb.18.7.3926  0.372
1998 Ozer J, Mitsouras K, Zerby D, Carey M, Lieberman PM. Transcription factor IIA derepresses TATA-binding protein (TBP)-associated factor inhibition of TBP-DNA binding. The Journal of Biological Chemistry. 273: 14293-300. PMID 9603936 DOI: 10.1074/jbc.273.23.14293  0.448
1998 Ozer J, Lezina LE, Ewing J, Audi S, Lieberman PM. Association of transcription factor IIA with TATA binding protein is required for transcriptional activation of a subset of promoters and cell cycle progression in Saccharomyces cerevisiae. Molecular and Cellular Biology. 18: 2559-70. PMID 9566876 DOI: 10.1128/Mcb.18.5.2559  0.446
1997 Kim AL, Maher M, Hayman JB, Ozer J, Zerby D, Yates JL, Lieberman PM. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha. Virology. 239: 340-51. PMID 9434725 DOI: 10.1006/Viro.1997.8874  0.577
1997 Lieberman PM, Ozer J, Gürsel DB. Requirement for transcription factor IIA (TFIIA)-TFIID recruitment by an activator depends on promoter structure and template competition. Molecular and Cellular Biology. 17: 6624-32. PMID 9343426 DOI: 10.1128/Mcb.17.11.6624  0.456
1997 Zerby D, Lieberman PM. Functional analysis of TFIID-activator interaction by magnesium-agarose gel electrophoresis Methods: a Companion to Methods in Enzymology. 12: 217-223. PMID 9237166 DOI: 10.1006/Meth.1997.0474  0.506
1996 Kirov NC, Lieberman PM, Rushlow C. The transcriptional corepressor DSP1 inhibits activated transcription by disrupting TFIIA-TBP complex formation. The Embo Journal. 15: 7079-87. PMID 9003783  0.38
1996 Sarisky RT, Gao Z, Lieberman PM, Fixman ED, Hayward GS, Hayward SD. A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator. Journal of Virology. 70: 8340-7. PMID 8970953 DOI: 10.1128/Jvi.70.12.8340-8347.1996  0.532
1996 Martin ML, Lieberman PM, Curran T. Fos-Jun dimerization promotes interaction of the basic region with TFIIE-34 and TFIIF. Molecular and Cellular Biology. 16: 2110-8. PMID 8628277 DOI: 10.1128/Mcb.16.5.2110  0.38
1996 Ozer J, Bolden AH, Lieberman PM. Transcription factor IIA mutations show activator-specific defects and reveal a IIA function distinct from stimulation of TBP-DNA binding. The Journal of Biological Chemistry. 271: 11182-90. PMID 8626665 DOI: 10.1074/Jbc.271.19.11182  0.484
1996 Sarisky RT, Gao Z, Lieberman PM, Fixman ED, Hayward GS, Hayward SD. A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator. Journal of Virology. 70: 8340-8347. DOI: 10.1128/jvi.70.12.8340-8347.1996  0.304
1995 Mallo M, Lieberman PM, Gridley T. Possible involvement of the mouse Grg protein in transcription Cellular &Amp; Molecular Biology Research. 41: 435-440. PMID 8867791  0.425
1995 Chi T, Lieberman P, Ellwood K, Carey M. A general mechanism for transcriptional synergy by eukaryotic activators. Nature. 377: 254-7. PMID 7675113 DOI: 10.1038/377254a0  0.325
1994 Lieberman P. Identification of functional targets of the Zta transcriptional activator by formation of stable preinitiation complex intermediates. Molecular and Cellular Biology. 14: 8365-75. PMID 7969171 DOI: 10.1128/mcb.14.12.8365-8375.1994  0.37
1994 Lieberman PM, Berk AJ. A mechanism for TAFs in transcriptional activation: Activation domain enhancement of TFIID-TFIIA-promoter DNA complex formation Genes and Development. 8: 995-1006. PMID 7926793 DOI: 10.1101/Gad.8.9.995  0.399
1993 Ryon JJ, Fixman ED, Houchens C, Zong J, Lieberman PM, Chang YN, Hayward GS, Hayward SD. The lytic origin of herpesvirus papio is highly homologous to Epstein-Barr virus ori-Lyt: evolutionary conservation of transcriptional activation and replication signals. Journal of Virology. 67: 4006-16. PMID 8389916 DOI: 10.1128/Jvi.67.7.4006-4016.1993  0.403
1993 Clark ME, Lieberman PM, Berk AJ, Dasgupta A. Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro Molecular and Cellular Biology. 13: 1232-1237. PMID 8380894 DOI: 10.1128/mcb.13.2.1232-1237.1993  0.33
1993 Ryon JJ, Fixman ED, Houchens C, Zong J, Lieberman PM, Chang YN, Hayward GS, Hayward SD. The lytic origin of herpesvirus papio is highly homologous to Epstein-Barr virus ori-Lyt: evolutionary conservation of transcriptional activation and replication signals. Journal of Virology. 67: 4006-4016. DOI: 10.1128/jvi.67.7.4006-4016.1993  0.36
1992 Kasai Y, Nambu JR, Lieberman PM, Crews ST. Dorsal-ventral patterning in Drosophila: DNA binding of snail protein to the single-minded gene. Proceedings of the National Academy of Sciences of the United States of America. 89: 3414-8. PMID 1533042 DOI: 10.1073/Pnas.89.8.3414  0.314
1992 Zhou Q, Lieberman PM, Boyer TG, Berk AJ. Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter Genes and Development. 6: 1964-1974. PMID 1398073 DOI: 10.1101/Gad.6.10.1964  0.363
1991 Lieberman PM, Schmidt MC, Kao CC, Berk AJ. Two distinct domains in the yeast transcription factor IID and evidence for a TATA box-induced conformational change. Molecular and Cellular Biology. 11: 63-74. PMID 1986253 DOI: 10.1128/mcb.11.1.63-74.1991  0.355
1991 Lieberman PM, Berk AJ. The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction Genes &Amp; Development. 5: 2441-2454. PMID 1661258  0.428
1990 Kao CC, Lieberman PM, Schmidt MC, Zhou Q, Pei R, Berk AJ. Cloning of a transcriptionally active human TATA binding factor. Science (New York, N.Y.). 248: 1646-50. PMID 2194289 DOI: 10.1126/Science.2194289  0.492
1990 Lieberman PM, Berk AJ. In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein Journal of Virology. 64: 2560-2568. PMID 2159531  0.484
1990 Lieberman PM, Hardwick JM, Sample J, Hayward GS, Hayward SD. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. Journal of Virology. 64: 1143-55. PMID 2154599 DOI: 10.1128/Jvi.64.3.1143-1155.1990  0.418
1990 Lieberman PM, Hardwick JM, Sample J, Hayward GS, Hayward SD. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. Journal of Virology. 64: 1143-1155. DOI: 10.1128/jvi.64.3.1143-1155.1990  0.333
1989 Lieberman PM, Hardwick JM, Hayward SD. Responsiveness of the Epstein-Barr virus NotI repeat promoter to the Z transactivator is mediated in a cell-type-specific manner by two independent signal regions. Journal of Virology. 63: 3040-50. PMID 2542612  0.387
1986 Lieberman PM, O'Hare P, Hayward GS, Hayward SD. Promiscuous trans activation of gene expression by an Epstein-Barr virus-encoded early nuclear protein. Journal of Virology. 60: 140-8. PMID 3018281 DOI: 10.1128/Jvi.60.1.140-148.1986  0.414
Show low-probability matches.